JP2006511520A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006511520A5 JP2006511520A5 JP2004559355A JP2004559355A JP2006511520A5 JP 2006511520 A5 JP2006511520 A5 JP 2006511520A5 JP 2004559355 A JP2004559355 A JP 2004559355A JP 2004559355 A JP2004559355 A JP 2004559355A JP 2006511520 A5 JP2006511520 A5 JP 2006511520A5
- Authority
- JP
- Japan
- Prior art keywords
- prophylaxis
- inhibiting
- risk
- reducing
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010003210 Arteriosclerosis Diseases 0.000 claims 1
- 208000011775 arteriosclerosis disease Diseases 0.000 claims 1
- 208000026106 cerebrovascular disease Diseases 0.000 claims 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 1
- 208000029078 coronary artery disease Diseases 0.000 claims 1
- 230000002526 effect on cardiovascular system Effects 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000011321 prophylaxis Methods 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 238000011282 treatment Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/316,424 US20040115265A1 (en) | 2002-12-11 | 2002-12-11 | Multilayered tablet containing pravastatin and aspirin and method |
| PCT/US2003/038774 WO2004052289A2 (en) | 2002-12-11 | 2003-12-03 | Multilayered tablet containing pravastatin and aspirin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006511520A JP2006511520A (ja) | 2006-04-06 |
| JP2006511520A5 true JP2006511520A5 (enExample) | 2006-12-14 |
Family
ID=32505946
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004559355A Pending JP2006511520A (ja) | 2002-12-11 | 2003-12-03 | プラバスタチンおよびアスピリン含有多層錠および方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20040115265A1 (enExample) |
| EP (1) | EP1581194B1 (enExample) |
| JP (1) | JP2006511520A (enExample) |
| AT (1) | ATE401061T1 (enExample) |
| AU (1) | AU2003297689A1 (enExample) |
| CY (1) | CY1108414T1 (enExample) |
| DE (1) | DE60322264D1 (enExample) |
| DK (1) | DK1581194T3 (enExample) |
| ES (1) | ES2308040T3 (enExample) |
| IS (1) | IS2877B (enExample) |
| MY (1) | MY140947A (enExample) |
| NO (1) | NO338696B1 (enExample) |
| PL (1) | PL206190B1 (enExample) |
| PT (1) | PT1581194E (enExample) |
| SI (1) | SI1581194T1 (enExample) |
| TW (1) | TWI361700B (enExample) |
| WO (1) | WO2004052289A2 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004096201A1 (en) | 2003-04-29 | 2004-11-11 | Orexigen Therapeutics, Inc. | Compositions for affecting weight loss |
| US8163797B2 (en) * | 2003-12-31 | 2012-04-24 | Actavis Elizabeth Llc | Method of treating with stable pravastatin formulation |
| EP1830832A1 (en) * | 2004-12-30 | 2007-09-12 | Genzyme Corporation | Zinc-containing treatments for hyperphosphatemia |
| US20060251722A1 (en) * | 2005-05-03 | 2006-11-09 | Novavax, Inc. | Multi-component vitamin and mineral supplement for the optimal absorption of components |
| WO2007027566A2 (en) * | 2005-09-02 | 2007-03-08 | Genzyme Corporation | Method for removing phosphate and polymer used therefore |
| JP2009514966A (ja) * | 2005-11-08 | 2009-04-09 | ジェンザイム・コーポレーション | 高リン血症のためのマグネシウム含有重合体 |
| ES2761812T3 (es) | 2005-11-22 | 2020-05-21 | Nalpropion Pharmaceuticals Inc | Composición y métodos de aumento de la sensibilidad a la insulina |
| WO2007072060A2 (en) * | 2005-12-23 | 2007-06-28 | Cipla Limited | Particles comprising a core containing a hmg-coa reductase inhibitor and coated with a film |
| EP1970055B1 (en) | 2005-12-29 | 2010-11-24 | Osmotica Kereskedelmi És Szolgáltató Kft | Multi-layered tablet with triple release combination |
| US8916195B2 (en) | 2006-06-05 | 2014-12-23 | Orexigen Therapeutics, Inc. | Sustained release formulation of naltrexone |
| WO2008005217A2 (en) * | 2006-07-05 | 2008-01-10 | Genzyme Corporation | Iron(ii)-containing treatments for hyperphosphatemia |
| US8765178B2 (en) * | 2006-07-19 | 2014-07-01 | Watson Laboratories, Inc. | Controlled release formulations and associated methods |
| KR20150082689A (ko) | 2006-11-09 | 2015-07-15 | 오렉시젠 세러퓨틱스 인크. | 단위 용량 팩키지 |
| DK2089005T3 (da) * | 2006-11-09 | 2010-07-19 | Orexigen Therapeutics Inc | Lagdelte farmaceutiske formuleringer omfattende et hurtigt opløsende mellemlag |
| WO2008112706A1 (en) | 2007-03-13 | 2008-09-18 | Nutrition 21, Inc. | Methods and compositions for the sustained release of chromium |
| WO2009002867A2 (en) | 2007-06-26 | 2008-12-31 | Nutrition 21, Inc. | Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement |
| KR101330096B1 (ko) * | 2007-10-12 | 2013-11-15 | 페링 인터내셔널 센터 에스 에이 | 구연산, 산화 마그네슘, 중탄산칼륨 및 피코황산나트륨을 포함하는 의약품의 제조 방법, 이러한 방법에 의해 제조된 과립을 포함하는 약제학적 조성물 및 중간체 |
| WO2009158114A1 (en) | 2008-05-30 | 2009-12-30 | Orexigen Therapeutics, Inc. | Methods for treating visceral fat conditions |
| CN102724878A (zh) | 2010-01-11 | 2012-10-10 | 奥雷西根治疗公司 | 在重度抑郁症患者中提供体重减轻疗法的方法 |
| TR201005325A2 (tr) | 2010-06-30 | 2012-01-23 | Bi̇lgi̇ç Mahmut | Atorvastatin ve aspirin içeren farmasötik formülasyonlar |
| KR20120068277A (ko) * | 2010-12-17 | 2012-06-27 | 한미사이언스 주식회사 | ＨＭＧ－ＣｏＡ 환원효소 억제제 및 아스피린을 포함하는 약제학적 복합제제 |
| JP5905031B2 (ja) * | 2011-01-28 | 2016-04-20 | インタッチ テクノロジーズ インコーポレイテッド | モバイルテレプレゼンスロボットとのインタフェーシング |
| HUE072188T2 (hu) | 2012-06-06 | 2025-10-28 | Nalpropion Pharmaceuticals Llc | Készítmény magas kardiovaszkuláris kockázatú túlsúlyos és elhízott páciensek kezelésére szolgáló eljárásban történõ alkalmazásra |
| EP2810644A1 (en) * | 2013-06-06 | 2014-12-10 | Ferrer Internacional, S.A. | Oral formulation for the treatment of cardiovascular diseases |
| GB2564295A (en) | 2016-02-11 | 2019-01-09 | Nutrition 21 Llc | Chromium containing compositions for improving health and fitness |
| JP7109748B2 (ja) * | 2018-12-11 | 2022-08-01 | 日本ジェネリック株式会社 | アジルサルタンとアムロジピンベシル酸塩含有固形製剤及び固形製剤の製造方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4590183A (en) * | 1985-04-22 | 1986-05-20 | Sterling Drug Inc. | Gastric cytoprotection with sodium thiosulfate in oral administration of aspirin |
| JP3172749B2 (ja) * | 1992-02-17 | 2001-06-04 | ライオン株式会社 | イブプロフェン含有製剤 |
| IT1255522B (it) * | 1992-09-24 | 1995-11-09 | Ubaldo Conte | Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita' |
| IT1264517B1 (it) * | 1993-05-31 | 1996-09-24 | Ekita Investments Nv | Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati |
| FR2772615B1 (fr) * | 1997-12-23 | 2002-06-14 | Lipha | Comprime multicouche pour la liberation instantanee puis prolongee de substances actives |
| US6235311B1 (en) * | 1998-03-18 | 2001-05-22 | Bristol-Myers Squibb Company | Pharmaceutical composition containing a combination of a statin and aspirin and method |
| EP1063973B1 (en) * | 1998-03-19 | 2016-11-16 | Bristol-Myers Squibb Company | Biphasic controlled release delivery system for high solubility pharmaceuticals and method |
| US6669955B2 (en) * | 2001-08-28 | 2003-12-30 | Longwood Pharmaceutical Research, Inc. | Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin |
-
2002
- 2002-12-11 US US10/316,424 patent/US20040115265A1/en not_active Abandoned
-
2003
- 2003-12-03 WO PCT/US2003/038774 patent/WO2004052289A2/en not_active Ceased
- 2003-12-03 EP EP03812825A patent/EP1581194B1/en not_active Expired - Lifetime
- 2003-12-03 AT AT03812825T patent/ATE401061T1/de active
- 2003-12-03 PL PL377265A patent/PL206190B1/pl unknown
- 2003-12-03 ES ES03812825T patent/ES2308040T3/es not_active Expired - Lifetime
- 2003-12-03 AU AU2003297689A patent/AU2003297689A1/en not_active Abandoned
- 2003-12-03 PT PT03812825T patent/PT1581194E/pt unknown
- 2003-12-03 DE DE60322264T patent/DE60322264D1/de not_active Expired - Lifetime
- 2003-12-03 DK DK03812825T patent/DK1581194T3/da active
- 2003-12-03 SI SI200331302T patent/SI1581194T1/sl unknown
- 2003-12-03 JP JP2004559355A patent/JP2006511520A/ja active Pending
- 2003-12-08 TW TW092134590A patent/TWI361700B/zh active
- 2003-12-10 MY MYPI20034728A patent/MY140947A/en unknown
-
2005
- 2005-06-07 NO NO20052734A patent/NO338696B1/no not_active IP Right Cessation
- 2005-06-10 IS IS7889A patent/IS2877B/is unknown
-
2008
- 2008-10-14 CY CY20081101137T patent/CY1108414T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005082863A3 (en) | 1,4 diaryl-dihydropyrimidin-2 ones and their use as a human neutrophil elastase inhibitors | |
| ATE516285T1 (de) | Dihydropyridinonderivate | |
| NO20071930L (no) | t4Metoder og sammensetninger til behandling av hyperlipidemi. | |
| PL2482078T3 (pl) | Diagnozowanie choroby sercowo-naczyniowej | |
| NO20070247L (no) | Amino-5,5-difenylimidazolonderivater for inhibisjon av beta-sekretase | |
| IL189500A (en) | 4, 2-Diaminopyrimidines are preserved in position 5, containing pharmaceutical preparations and using them to prepare a drug for the treatment of 3x2p receptor mediated diseases and 2/3 x2p | |
| DE50311502D1 (de) | Neue arzneimittel zur behandlung von chronisch obstruktiver lungenerkrankung | |
| GB0412753D0 (en) | Pharmaceutical compositions for the treatment of disease and/or symptoms in arthritis | |
| LT2878297T (lt) | Medikamentai, skirti fibrozinių ligų gydymui arba prevencijai | |
| NO20041452L (no) | 17-beta-hydroksysteroid-dehydrogenase type 3-inhibitorer for behandling av androgenavhengige sykdommer. | |
| NO20053860D0 (no) | COP 1 for behandling av inflammatorisk tarmsykdom. | |
| WO2006034003A3 (en) | Compounds, compositions and methods of inhibiting a-synuclein toxicity | |
| EP1635815A4 (en) | METHOD AND COMPOUNDS FOR TREATING TISSUE TESTS | |
| WO2003031650A3 (en) | Genes and proteins for prevention, prediction, prognosis and therapy of cardiovascular disease | |
| IL177787A0 (en) | 1-aminovyclohexane derivatives for the treatment of agitation and other behavioral disorders, especially those associated with alzheimer's disease | |
| GB0514501D0 (en) | Pharmaceutical compounds | |
| NO20100477L (no) | Anvendelse av risendronat til fremstilling av medikamenter for behandling og prevensjon av osteoporose | |
| WO2006025924A3 (en) | Alpha, beta-unsaturated sulfones, sulfoxides, sulfonimides, sulfinimides, acylsulfonamides and acylsulfinamides and therapeutic uses thereof | |
| WO2004024167A3 (fr) | Utilisation de prebiotiques, preferentiellement le glucooligosaccharide, pour la prevention de l’installation du diabete de type ii | |
| ZA200104616B (en) | Diazepinoindoles for the treatment of chronic obstructive pulmonary disease. | |
| DE602006012332D1 (de) | Kombination von verbindungen, die bei der behandlung von atemwegserkrankungen verwendet werden können, insbesondere bei chronisch obstruktiver lungenerkrankung (copd) und asthma | |
| WO2006138043A3 (en) | Method and compositions for the treatment of diabetes and related complications | |
| EP1896074A4 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF CORONARY ARTERY DISEASE | |
| JP2007512260A5 (enExample) | ||
| EP1543166A4 (en) | SYNERGETIC COMPOSITIONS FOR PREVENTING AND TREATING THE ACQUIRED IMMUNE WEAKNESS SYNDROME |